Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Asjad Visnagri, Amit D. Kandhare, Shalendra Chakravarty, Pinaki Ghosh & Subhash L. Bodhankar. (2014) Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharmaceutical Biology 52:7, pages 814-828.
Read now
Read now
Christina Voulgari & Nicholas Tentolouris. (2009) Combination of nateglinide with thiazolidinediones in Type 2 diabetes. Expert Review of Endocrinology & Metabolism 4:6, pages 537-552.
Read now
Read now
Alastair Clarke & Marie-Paule Dain. (2006) Dose accuracy of a reusable insulin pen using a cartridge system with an integrated plunger mechanism. Expert Opinion on Drug Delivery 3:5, pages 677-683.
Read now
Read now
Articles from other publishers (38)
Bei Tan, Xueqing Wu, Jie Yu & Zhong Chen. (2022) The Role of Saponins in the Treatment of Neuropathic Pain. Molecules 27:12, pages 3956.
Crossref
Crossref
Matthew Quigley, Arul Earnest, Naomi Szwarcbard, Natalie Wischer, Sofianos Andrikopoulos, Sally Green & Sophia Zoungas. (2022) Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors. PLOS ONE 17:2, pages e0263511.
Crossref
Crossref
Monica Choo, Gregory E. Hoy, Sarah P. Dugan, Laura N. McEwen, Naresh Gunaratnam, Jennifer Wyckoff, Thangarasa Jeevaraaj, Arunachalam Saththiyaseelan, B. Ganeikabahu, Prasad Katulanda, Ulysses Balis, William H. Herman & Anjan K. Saha. (2020) Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study. BMJ Open 10:7, pages e038148.
Crossref
Crossref
Li Wang, Ting He, Adan Fu, Zhijin Mao, Lan Yi, Sha Tang & Jing Yang. (2018) Hesperidin enhances angiogenesis via modulating expression of growth and inflammatory factor in diabetic foot ulcer in rats. European Journal of Inflammation 16, pages 205873921877525.
Crossref
Crossref
Aleksandra Maleska, Christophe Hirtz, Elise Casteleyn, Orianne Villard, Jacques Ducos, Antoine Avignon, Ariane Sultan & Sylvain Lehmann. (2017) Comparison of HbA1c detection in whole blood and dried blood spots using an automated ion-exchange HPLC system. Bioanalysis 9:5, pages 427-434.
Crossref
Crossref
Gianluca Bardini, Maddalena Innocenti, Carlo Maria Rotella, Stefano Giannini & Edoardo Mannucci. (2016) Variability of triglyceride levels and incidence of microalbuminuria in type 2 diabetes. Journal of Clinical Lipidology 10:1, pages 109-115.
Crossref
Crossref
Rafael Pérez-Escamilla, Grace Damio, Jyoti Chhabra, Maria L. Fernandez, Sofia Segura-Pérez, Sonia Vega-López, Grace Kollannor-Samuel, Mariana Calle, Fatma M. Shebl & Darrin D’Agostino. (2015) Impact of a Community Health Workers–Led Structured Program on Blood Glucose Control Among Latinos With Type 2 Diabetes: The DIALBEST Trial. Diabetes Care 38:2, pages 197-205.
Crossref
Crossref
Amlan Barua, Jhankar Acharya, Saroj Ghaskadbi & Pranay Goel. (2014) The relationship between fasting plasma glucose and HbA1c during intensive periods of glucose control in antidiabetic therapy. Journal of Theoretical Biology 363, pages 158-163.
Crossref
Crossref
Amit D. Kandhare, Pinaki Ghosh & Subhash L. Bodhankar. (2014) Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats. Chemico-Biological Interactions 219, pages 101-112.
Crossref
Crossref
Ruth E. Brown, Michael C. Riddell, Alison K. Macpherson, Karissa L. Canning & Jennifer L. Kuk. (2014) All-cause and cardiovascular mortality risk in U.S. adults with and without type 2 diabetes: Influence of physical activity, pharmacological treatment and glycemic control. Journal of Diabetes and its Complications 28:3, pages 311-315.
Crossref
Crossref
Wing-Bun Chan, Wilson W. M. Ngai & Peter Chun-Yip Tong. (2014) Treatment Satisfaction with Insulin Glargine in Insulin-Naïve Type 2 Diabetes Patients—A Hong Kong Based Registry. Journal of Diabetes Mellitus 04:03, pages 232-241.
Crossref
Crossref
Chiara Toffanin, Alice Sandri, Mirko Messori, Claudio Cobelli & Lalo Magni. (2014) Automatic adaptation of basal therapy for Type 1 diabetic patients: a Run-to-Run approach. IFAC Proceedings Volumes 47:3, pages 2070-2075.
Crossref
Crossref
Viren Ranawana & Bhupinder Kaur. 2013.
1
47
.
Geoffrey Livesey. 2012. Sweeteners and Sugar Alternatives in Food Technology. Sweeteners and Sugar Alternatives in Food Technology
1
26
.
Yajing Li, Minli Chen, Hongzhuan Xuan & Fuliang Hu. (2012) Effects of Encapsulated Propolis on Blood Glycemic Control, Lipid Metabolism, and Insulin Resistance in Type 2 Diabetes Mellitus Rats. Evidence-Based Complementary and Alternative Medicine 2012, pages 1-8.
Crossref
Crossref
Maria Magdalena Bujnowska-FedakEdward PuchałaAndrzej Steciwko. (2011) The Impact of Telehome Care on Health Status and Quality of Life Among Patients with Diabetes in a Primary Care Setting in Poland. Telemedicine and e-Health 17:3, pages 153-163.
Crossref
Crossref
Markolf Hanefeld, Andreas Pfützner, Thomas Forst, Iris Kleine & Winfried Fuchs. (2011) Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of Pioglitazone, Metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study. Cardiovascular Diabetology 10:1, pages 65.
Crossref
Crossref
Jens Gundgaard, Torsten E. Christensen & Trine Lyager Thomsen. (2010) Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen. Primary Care Diabetes 4:3, pages 165-172.
Crossref
Crossref
Irina G. Obrosova, Roman Stavniichuk, Viktor R. Drel, Hanna Shevalye, Igor Vareniuk, Jerry L. Nadler & Robert. E. Schmidt. (2010) Different Roles of 12/15-Lipoxygenase in Diabetic Large and Small Fiber Peripheral and Autonomic Neuropathies. The American Journal of Pathology 177:3, pages 1436-1447.
Crossref
Crossref
Lisa M. Nilsson-BerglundAnna V. ZetterqvistJenny Nilsson-ÖhmanMikael SigvardssonLaura V. González BoscMaj-Lis SmithAlbert SalehiElisabet AgardhGunilla Nordin FredriksonCarl-David AgardhJan NilssonBrian R. WamhoffAnna Hultgårdh-NilssonMaria F. Gomez. (2010) Nuclear Factor of Activated T Cells Regulates Osteopontin Expression in Arterial Smooth Muscle in Response to Diabetes-Induced Hyperglycemia. Arteriosclerosis, Thrombosis, and Vascular Biology 30:2, pages 218-224.
Crossref
Crossref
Mona BoazKaterina HellmanJulio Wainstein. (2009) An Automated Telemedicine System Improves Patient-Reported Well-Being. Diabetes Technology & Therapeutics 11:3, pages 181-186.
Crossref
Crossref
G. De Mattia, O. Laurenti & A. Moretti. (2008) Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study. Acta Diabetologica 46:1, pages 67-73.
Crossref
Crossref
C. Tesseromatis, A. Kotsiou, H. Parara, E. Vairaktaris & M. Tsamouri. (2009) Morphological Changes of Gingiva in Streptozotocin Diabetic Rats. International Journal of Dentistry 2009, pages 1-4.
Crossref
Crossref
Yongmei Liu, Barry I. Freedman, Kathryn P. Burdon, Carl D. Langefeld, Timothy Howard, David Herrington, David C. GoffJrJr, Donald W. Bowden, Lynne E. Wagenknecht, Catherine C. Hedrick & Stephen S. Rich. (2008) Association of Arachidonate 12-Lipoxygenase Genotype Variation and Glycemic Control With Albuminuria in Type 2 Diabetes. American Journal of Kidney Diseases 52:2, pages 242-250.
Crossref
Crossref
M. Davies, F. Lavalle-González, F. Storms & R. Gomis. (2008) Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial. Diabetes, Obesity and Metabolism 10:5, pages 387-399.
Crossref
Crossref
Reinhard G Bretzel, Ulrike Nuber, Wolfgang Landgraf, David R Owens, Clare Bradley & Thomas Linn. (2008) Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. The Lancet 371:9618, pages 1073-1084.
Crossref
Crossref
Oliver J. Bott, Ina Hoffmann, Joachim Bergmann, Nathalie Gusew, Oliver Schnell, Enrique J. Gómez, M. Elena Hernando, Patrick Kosche, Christian von Ahn, Dirk C. Mattfeld & Dietrich P. Pretschner. (2007) HIS modelling and simulation based cost–benefit analysis of a telemedical system for closed-loop diabetes therapy. International Journal of Medical Informatics 76, pages S447-S455.
Crossref
Crossref
Eckhard Salzsieder, Petra Augstein, Lutz Vogt, Klaus-Dieter Kohnert, Peter Heinke, Ernst-Joachim Freyse, Abdel Azim Ahmed, Zakia Metwali, Iman Salman & Omer Attef. (2016) Telemedicine-Based KADIS® Combined with CGMS™ Has High Potential for Improving Outpatient Diabetes Care. Journal of Diabetes Science and Technology 1:4, pages 511-521.
Crossref
Crossref
Carol KeigherGloria AvalosFidelma Dunne. (2016) Treating to target in type 2 diabetes. The British Journal of Diabetes & Vascular Disease 7:2, pages 83-85.
Crossref
Crossref
Jun-Xian Yu, Yin-Di Zhang, Xiao-Xing Yin, Jian-Ping Shen, Jun Qiu, Hong-Lin Yin & Shao-Jun Jiang. (2006) PROTECTIVE EFFECTS OF BENDAZAC LYSINE ON DIABETIC PERIPHERAL NEUROPATHY IN STREPTOZOTOCIN-INDUCED DIABETIC RATS. Clinical and Experimental Pharmacology and Physiology 33:12, pages 1231-1238.
Crossref
Crossref
Takashi Sakurai & Koichi Yokono. (2006) Comprehensive studies of cognitive impairment of the elderly with type 2 diabetes. Geriatrics and Gerontology International 6:3, pages 159-164.
Crossref
Crossref
Bruce Frier, Pearl Yang & Albert W. Taylor. (2006) Diabetes, aging and physical activity. European Review of Aging and Physical Activity 3:2.
Crossref
Crossref
Taichi Akisaki, Takashi Sakurai, Toshihiro Takata, Hiroyuki Umegaki, Atsushi Araki, Sachiko Mizuno, Shiro Tanaka, Yasuo Ohashi, Akihisa Iguchi, Koichi Yokono & Hideki Ito. (2006) Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes/Metabolism Research and Reviews 22:5, pages 376-384.
Crossref
Crossref
Geoffrey Livesey. 2006. Sweeteners and Sugar Alternatives in Food Technology. Sweeteners and Sugar Alternatives in Food Technology
1
18
.
Junxian YuYindi ZhangShi SunJianping ShenJun QiuXiaoxing YinHonglin YinShaojun Jiang. (2006) Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Canadian Journal of Physiology and Pharmacology 84:6, pages 579-587.
Crossref
Crossref
Jenny NilssonLisa M. NilssonYung-Wu ChenJeffery D. MolkentinDavid ErlingeMaria F. Gomez. (2006) High Glucose Activates Nuclear Factor of Activated T Cells in Native Vascular Smooth Muscle. Arteriosclerosis, Thrombosis, and Vascular Biology 26:4, pages 794-800.
Crossref
Crossref
Claude Cao, Jens P. Hellermann, Markus Weber & Patrice M. Ambühl. (2006) Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades. Nephrology Dialysis Transplantation 21:3, pages 770-775.
Crossref
Crossref
Jaime A. Davidson. (2005) Case study: Lessons learned in the care of a 63-year-old woman with type 2 diabetes. Clinical Cornerstone 7, pages S18-S24.
Crossref
Crossref